The candidate MCMs delivered by Leidos to TFF Pharmaceuticals have been successfully formulated utilizing the Company’s proprietary Thin Film Freezing technology platform. Formulated materials have ...
As steadily increasing numbers of mRNA vaccines and therapeutics advance through clinical trials and commercialization, the biopharmaceutical industry is pressed to find ways to make their production ...
Upstream and downstream bioprocessing rely on various forms of filtration. Some of the most widely used methods include a tangential flow filter (TFF). Instead of flowing through a filter, a sample ...
Statements made in this press release regarding matters that are not historical facts are “forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (Nasdaq: TFFP), an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Feasibility work underway to determine the compatibility of NeuroRx’s ZYESAMI™ (aviptadil, synthetic VIP) as a dry powder formulation using TFF’s Thin-Film Freezing technology RADNOR, Pa. & AUSTIN, ...
TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles. TFF Pharmaceuticals, a clinical-stage biopharmaceutical company, and Catalent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results